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Abstract
Introduction Dietary exposure monitoring within populations is reliant on self-reported measures such as Food Frequency 
Questionnaires and diet diaries. These methods often contain inaccurate information due to participant misreporting, non-
compliance and bias. Urinary metabolites derived from individual foods could provide additional objective indicators of 
dietary exposure. For biomarker approaches to have utility it is essential that they cover a wide-range of commonly consumed 
foods and the methodology works in a real-world environment.
Objectives To test that the methodology works in a real-world environment and to consider the impact of the major sources 
of likely variance; particularly complex meals, different food formulations, processing and cooking methods, as well as the 
dynamics of biomarker duration in the body.
Methods We designed and tested a dietary exposure biomarker discovery and validation strategy based on a food interven-
tion study involving free-living individuals preparing meals and collecting urine samples at home. Two experimental periods 
were built around three consecutive day menu plans where all foods and drinks were provided (n = 15 and n = 36).
Results The experimental design was validated by confirming known consumption biomarkers in urinary samples after the 
first menu plan. We tested biomarker performance with different food formulations and processing methods involving meat, 
wholegrain, fruits and vegetables.
Conclusion It was demonstrated that spot urine samples, together with robust dietary biomarkers, despite major sources of 
variance, could be used successfully for dietary exposure monitoring in large epidemiological studies.
Keywords Dietary biomarkers · Free-living population · Healthy eating policies · High resolution metabolomics
1 Introduction
A key factor in effective implementation of public health 
strategies is the need for validated population-level dietary 
exposure screening methods with which to determine the 
effectiveness of ‘healthy eating’ interventions to change eat-
ing habits. To date, assessment of dietary exposure has relied 
on self-reported measures of intake derived using tools such 
as Food Frequency Questionnaires, dietary recall and diet 
diaries (Penn et al. 2010). However these methods have 
well understood limitations as a result of misreporting and 
bias, and depend upon food composition tables for estima-
tion of intakes of energy, nutrients and other food constitu-
ents (Bingham et al. 1994). These limitations may be over-
come, at least in part, by the demonstration that metabolites 
derived from specific foods or food groups present in urine 
samples provide biomarkers of dietary exposure (Lee et al. 
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2006; Lovegrove et al. 2004; Marklund et al. 2010). Urinary 
dietary exposure biomarkers are based on the concept that 
urinary excretion of specific metabolite(s) reflects, quantita-
tively, intake of a corresponding food or nutrient over a fixed 
period of time. In some cases, multi-metabolite biomarker 
panels may provide more reliable estimation of dietary expo-
sure than a single-biomarker approach (reviewed by (Garcia-
Aloy et al. 2017)). To add value to the assessment of habitual 
dietary intake, a dietary biomarker panel should contain 
markers for a wide range of commonly consumed foods and 
these markers should be specific and sensitive. In addition, 
given the genotype-dependent inter-individual differences in 
metabolism of some food-derived components (van Duyn-
hoven et al. 2011), biomarkers panels should be based on 
metabolites that are universally applicable, where possible. 
The ideal biomarker is highly specific for one food item or 
food group, is not detected in the biological sample of inter-
est when the specific food item is not ingested, and shows a 
distinct dose- and time- dependent response following con-
sumption (Kristensen et al. 2012). At present, biomarker 
panels are not sufficiently comprehensive or well-validated 
to replace traditional dietary assessment methods and so, in 
practice, they should be used in combination with self-report 
methods to improve the accuracy of dietary intake measure-
ment (Potischman and Freudenheim 2003).
Several approaches have been used for the discovery of 
dietary biomarkers in urine. For example, in well-controlled 
dietary intervention studies, participants consume a single 
test food in isolation in a single meal or repeated meals and 
baseline and post prandial spot urine samples are collected 
over a few hours (Edmands et al. 2011; Lloyd et al. 2011b). 
Following this approach, we used non-targeted metabo-
lomics in combination with rapid metabolite fingerprinting 
methods to identify a range of potential biomarker candi-
dates for widely consumed foods that are relatively abundant 
and easily detected in urine (Fave et al. 2011; Lloyd et al. 
2011a; Lloyd et al. b; Primrose et al. 2011). In addition, 
using self-reported dietary data, participants in cohort stud-
ies can be classified into consumers and non/low consum-
ers of a particular food/food group and metabolite profiles/
fingerprints of representative bio-banked urine samples used 
to identify distinguishing metabolites which are assumed to 
be characteristic of the particular food/food group (Garcia-
Aloy et al. 2015; Gibbons et al. 2015). Lastly, attempts have 
been made to derive metabolic profiles/fingerprints that 
reflect dietary patterns rather than single foods/food groups 
(Garcia-Perez et al. 2017). With further development and 
validation, the latter approach could have wide utility but it’s 
associated with greater conceptual and practical challenges. 
These approaches are reviewed by (Gibbons and Brennan 
2017). Whilst these metabolomic-based approaches have led 
to the discovery of dietary biomarkers for several foods, cur-
rent approaches and study designs have multiple limitations.
For dietary biomarkers to have significant utility in the 
implementation of future public health policies, their perfor-
mance in real-world environments needs to be demonstrated. 
In real-life situations, foods are not usually consumed in 
isolation but rather as part of potentially complex meals in 
which they are co-consumed with other foods which may 
attenuate the ability to identify and to validate potential 
biomarkers of dietary exposure. In addition, different food 
preparation, processing and cooking methods may affect the 
stability, availability and biotransformation fate and, there-
fore concentration in urine, of metabolites that are potential 
food intake biomarkers. Further, the future utility of any 
biomarker panel will be enhanced greatly if its coverage of 
commonly-consumed foods is comprehensive. Currently, 
chemical biomarkers are available for only a relatively small 
number of specific foods and food components and most 
are of uncertain validity (Lee et al. 2006; Lovegrove et al. 
2004; Marklund et al. 2010). There are many foods and food 
groups of high public health relevance for which dietary 
exposure biomarkers are not yet available. Thus there is a 
need to populate dietary biomarker panels with new bio-
markers for a wider range of food/food groups, to enable 
them to provide independent, objective, and accurate esti-
mates of dietary exposure.
The Metabolomics at Aberystwyth, Imperial and New-
castle (MAIN) Study was designed to address some of these 
challenges. Here we describe the design and testing of a 
dietary exposure biomarker discovery strategy based on a 
comprehensive food intervention study that mimicked an 
annual eating pattern using commonly consumed foods as 
recorded by the National Diet and Nutrition Survey (NDNS) 
(Department of Health 2012). Free-living individuals pre-
pared and consumed the test foods and collected urine sam-
ples at home. We aimed to test the utility of this approach 
for efficient characterization of recent dietary exposure in 
free-living individuals sampled with minimal intrusion on 
normal daily activities.
2  Experimental methods
2.1  Ethical approval
A favorable ethical opinion was obtained following Pro-
portionate Review by the East Midlands—Nottingham 1 
National Research Ethics Committee (14/EM/0040). The 
trial was adopted into the UK Clinical Research Network 
(CRN) Portfolio (16037) and is registered with International 
Standard Randomized Controlled Trials Number (ISRCTN), 
88921234. All participants gave written informed consent, 
and the study was carried out in accordance with the Dec-
laration of Helsinki.
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2.2  Study design and urine sampling
The MAIN Study at Newcastle comprises two interrelated 
food interventions (Willis et al. Submitted), the first of 
which (Lloyd et al. Submitted) validated a food interven-
tion strategy designed to mimic an annual eating pattern in 
a home setting over a period of a few weeks and additionally 
developed methods for collecting spot urine samples suit-
able for deployment of biomarker measurement technology 
in free-living populations. The present manuscript focuses 
largely on the second intervention which explores the impact 
of portion size and food formulation or cooking method on 
biomarker performance. In brief, the project included two 
controlled food intervention studies in free-living popula-
tions who consumed the test foods within two three-day 
menu plans, equating to six different menus. We selected 
foods/food groups for menus using information on the top 
2–3 most highly consumed foods within food groups and 
used the most common preparation methods for these foods, 
as recorded by the NDNS years 1–3 (Department of Health 
2012), together with Public Health England policy advice 
from The Eatwell Plate (Food Standards Agency 2009) 
which has now been revised to The Eatwell Guide (Public 
Health England 2016). We used standard portion sizes based 
on the UK Food Standards Agency (Food Standards Agency 
1994) or manufacturers’ suggestions.
In the first study we employed a cross-over design in 
which, on the day before the study (Pre-day), participants 
were randomized to either a standardized evening meal 
(Supplemental data 1a) or a low polyphenol evening meal 
of their choosing (avoiding the foods listed in Supplemental 
data 1b). In the following week, participants were crossed-
over to the alternative pre-evening meal. The standardized 
evening meal was designed to minimize urine metabolome 
variability as the meal contained only food secondary metab-
olites likely to be digested and excreted without modification 
or excreted as well-described bio transformed metabolites, 
which were unaffected by the individuals’ gut microflora 
or general genetic disposition. Menu plans were followed 
on experimental days 1, 2 and 3 during which all foods and 
drinks were provided for participants in the portion sizes 
appropriate for UK conventional meals (breakfast, lunch, 
afternoon snack and dinner). These foods/drinks were pre-
pared, cooked and consumed by participants at home. The 
Post-day was the day following completion of the 3-day 
menu plan, when the last biological samples were collected. 
The pre-determined times for urine collection are described 
in (Lloyd et al. Submitted), but included post dinner (bed-
time), first morning void (FMV), fasting and post break-
fast and post lunch urine samples on each experimental day 
including the morning of the post-day. Participants collected 
urine samples in a plastic jug, recorded the volume together 
with the date, time and type of sample and transferred an 
aliquot to a labelled sterile 25 mL Universal tube. This sam-
ple was placed in an opaque cool bag, in the fridge at 4 °C. 
When transferred to the laboratory by the participant, further 
aliquots (2 mL) of all urine samples were made and were 
stored (Eppendorf tubes) at − 80 °C.
2.3  Urine sample preparation, extraction 
and adjustment
To take into account relative differences in fluid intake 
between participants all urine samples were normalized by 
refractive index prior to analysis to ensure all MS measure-
ments were made within a similar dynamic range. Refractive 
index normalization takes the total sample composition into 
account when normalising and not just the concentration of 
a single analyte. Refractive index normalization was selected 
over volume and creatinine normalization, as urine volumes 
are not always recorded successfully with spot samples and 
additionally it has been shown that there may be a gender 
bias present in urine creatinine concentrations (Ulaszewska 
et al. 2019). Samples were defrosted overnight in a 4 °C 
fridge. Once defrosted, samples were centrifuged (600×g for 
5 min at 4 °C), placed on ice and aliquots of thawed urine 
(1000 µL) was transferred into labelled 2 mL Eppendorf 
tubes. The remaining samples were returned to a − 20 °C 
freezer. An OPTI Hand Held Refractometer (Bellingham 
Stanley™ Brix 54 Model) was calibrated with de-ionised 
water  (dH2O) and dried with tissue according to the manu-
facturer’s instruction. Following this 220 µL of sample was 
transferred onto the refractometer dish, the specific gravity 
(SG) value was recorded in triplicate and temperature was 
noted. The refractometer was rinsed with  dH2O between 
samples and dried with tissue. Average SG values were 
calculated. Based on these figures, aliquots of the required 
amounts of urine from centrifuged 2 mL Eppendorf tubes 
and dH2O were transferred into new 2  mL Eppendorf 
tubes on ice to make up 500 µL for extraction. Pre-chilled 
(− 20 °C)  H2O: MeOH (3:7) was added to each adjusted 
sample and vortexed before being refrigerated at 4 °C over-
night, ready for analysis.
2.4  Flow infusion‑high resolution fingerprinting 
(FIE‑HRMS), multivariate modelling, 
classification and feature selection
We used a Thermo Exactive (Orbitrap) Mass Spectrometer 
(MS), equipped with an electrospray ionization source (ESI) 
and coupled to a Thermo Accela ultra-performance liquid 
chromatograph. Extracted urine samples were delivered to 
the electrospray source via a flow solvent (mobile phase) 
of pre-mixed HPLC grade MeOH (Fisher Scientific) and 
ultra-pure  H2O (18.2 Ω) at a ratio of 7:3. The flow rate was 
200 μL/min for the first 1.5 min, and 600 μL/min for the 
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remainder of the run. MS signals were collected from 55.000 
to 1000.000 m/z and from 63.000 to 1000.00 m/z for posi-
tive and negative mode respectively. RAW files were con-
verted to mzML open file format and centroided (Martens 
et al. 2011). Dimensionality reduction of the acquired mass 
spectra was performed by taking each m/z value from scans 
about the apex of the infusion profile and binning the m/z 
and intensity values at 0.01 amu intervals, allowing direct 
comparison of urine fingerprints, prior to signal annotation. 
This method has been described in detail elsewhere (Lloyd 
et al. Submitted; Wilson et al. Submitted)).
Supervised Random Forest (RF) classification was imple-
mented using the randomForest package in R (R Core Team 
2013). For all Random Forest models, the number of trees 
(ntree) used was 1000 and the number of variables consid-
ered at each internal node (mtry) was the square root of the 
total number of variables. RF margins of classification and 
area under the receiver operator characteristic (ROC) curve 
(AUC) were used to evaluate the performance of classifi-
cation models, as described previously (Enot et al. 2008). 
Models were deemed adequate if RF margins were > 0.2 
and AUC values were > 0.8, thresholds that we have imple-
mented in previous publications (Enot et al. 2008; Lloyd 
et al. 2016).
Signals discriminating between sample classes were 
selected using the following procedure. The fasting and 
the FMV sample of each experimental day was used as the 
baseline comparison with the subsequent post-prandial urine 
samples (post-breakfast, post-lunch and post-dinner) of that 
day to detect metabolite signals associated with exposure to 
food items consumed at particular times that day. In addi-
tion, for the post-dinner sample the subsequent fasting and 
the FMV (collected on the following day) was used as an 
additional comparison to allow detection of longer-duration 
markers, such as those derived from metabolism of the 
colonic microbiota and metabolites with longer half-lives 
e.g. because of temporary sequestration in tissues before 
excretion via the kidney. To reveal potential explanatory 
signals responsible for discriminating between baseline and 
post-prandial urine samples, a combination of RF, AUC 
and Student’s t test, (Enot et al. 2008) was employed. RF 
feature selection was performed by calculating Importance 
Scores, calculated as the mean decrease in accuracy over all 
classes when a feature was omitted from the data. AUC used 
the area under curve of the sensitivity (true-positive rate) 
against the specificity (false-positive rate) and Student’s t 
test ranked the features by the absolute value of the relevant 
P-values. The following thresholds were implemented to 
confidently identify discriminatory signals and metabolites: 
RF Importance scores > 0.002, P-values < 0.05, AUC 0.9. 
Lower thresholds indicated putative discriminatory biomark-
ers (RF Importance scores > 0.001 < 0.002, AUC > 0.8 < 0.9) 
and deemed worthy of investigating further. Randomized 
re-sampling strategies using bootstrapping were applied in 
the process of feature selection to counteract the effect of 
any unknown, structured variance in the data. We used 100 
bootstraps in pair-wise comparisons for each of the applied 
statistical operations with 2/3 of data as a training set and 
the remaining1/3 as the test set. RF was set to ntree = 1000 
for each bootstrap which is adequate considering the dimen-
sionality of data.
For metabolite signal annotation, accurate m/z values 
were extracted from the un-binned matrix to enable direct 
identification of metabolites at 1–5 ppm in the first pass pro-
file. These were queried using MZedDB, an interactive accu-
rate mass annotation tool used to annotate signals by means 
of neutral loss and/or adduct formation rules (Draper et al. 
2009). Ultra High Performance Liquid Chromatography-
High Resolution MS (UHPLC-HRMS) and Tandem mass 
spectrometry  (MSn) were used for further structural identifi-
cation of putative biomarkers as described elsewhere (Lloyd 
et al. 2017). Samples were analyzed on an Exactive Orbitrap 
(Thermo Scientific) mass spectrometer, coupled to an Accela 
Ultra UHPLC system (Thermo Scientific). Metabolites were 
annotated to Metabolomics Standards Initiative (MSI) level 
1 (Sumner et al. 2007) if they have matching masses,  MSn 
and retention times with authentic standards or the respec-
tive aglycone (if the biotransformation product was unavail-
able) run under the same conditions. MSI level 2 was used 
for putative matching compounds without standards (based 
upon physicochemical properties, retention times and spec-
tral similarity) reported in public/commercial spectral librar-
ies (Lipid Maps, HMDB, Metlin and Massbank (Horai et al. 
2010; Sana et al. 2008; Sud et al. 2007; Wishart et al. 2009)). 
MSI level 3 indicated a putatively characterized compound 
class (e.g. based upon characteristic physicochemical prop-
erties of a chemical class of compounds, or by spectral simi-
larity to known compounds of a chemical class).
2.5  Quantification using TSQ quantum ultra triple 
quadrupole (QQQ) technology
Quantitative analyses were performed on a TSQ Quantum 
Ultra triple quadrupole (QQQ) mass spectrometer (Thermo 
Scientific), equipped with an electro-spray ionization (ESI) 
source and coupled to an Accela UHPLC system (Thermo 
Scientific) following a protocol from (Wei et al. 2010). Tar-
geted metabolites together with column HILIC and RP-C18 
column chemistries, limit-of-detection (LOD) and limit-of-
quantification (LOQ) values are shown in Supplemental data 
2. Mass spectra were acquired in multiple reaction monitor-
ing (MRM) mode, in positive and negative ionization mode 
simultaneously, using optimized values of shimmer offset, 
collision energy, and tube lens for each MRM transition (see 
Supplemental data 2 for transitions).
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We calculated the mean concentrations of biomarkers 
in FMV urines the day after consumption and we defined 
whether the selected food/food group was consumed in a 
small, medium or large portion by looking at the FSA ‘Food 
portion sizes’ guide. We denoted a ‘large’ portion as > 1.5 X 
a suggested FSA medium portion size and a ‘small’ portion 
size as < 0.5 X a suggested FSA medium portion size (Food 
Standards Agency 1994).
Mean concentrations of putative biomarkers in FMV 
urines after consumption of the highest and lowest por-
tion sizes of selected dietary components were compared 
using the t test and correlations between portion size and 
biomarker concentration were performed using Spearman’s 
rank correlation.
3  Results and discussion
3.1  Utility of published biomarkers to detect 
dietary exposure in free‑living individuals
We first tested whether our flow-infusion high resolution MS 
fingerprinting biomarker discovery strategy was sufficiently 
sensitive to detect “known” biomarkers of specific foods 
when consumed by free-living individuals as components 
of conventional UK meals prepared and eaten at home. This 
was achieved by determining whether previously reported 
urinary biomarkers were highly ranked (i.e. RF Importance 
scores > 0.002, P-values < 0.05, AUC 0.9) in comparisons 
between fasting and post-prandial urine samples following 
acute exposure to specific foods (Table 1 and further signals 
in Supplemental data 3). Targeted foods included coffee, 
wholegrain, high-sugar foods, oily fish, cruciferous vegeta-
bles, grapes/wine and nuts (described in detail in (Lloyd 
et al. Submitted)). The majority of these markers appeared 
discriminatory i.e. detected the presence of the test food. In 
addition, in most cases, the nature of the meal consumed on 
the ‘Pre-day’ i.e. either a standardized evening meal (Sup-
plemental data 1a) or a non-standardized low polyphenol 
meal of the participant’s choice (Supplemental data 1b) did 
not affect the outcome. Based on RF IS and AUC values 
(Supplemental data 3), only three putative biomarkers i.e. 
5-(3′,4′,5′-trihydroxyphenyl)-γ-valerolactone sulfate, Feru-
lic acid 4-o-glucuronide and dihydroferulic acid-4-o-sulfate 
were not found to be discriminatory after the non-stand-
ardized meal when compared with the standardized meal. 
However, all three compounds are biotransformation prod-
ucts of other known biomarkers which functioned well and, 
therefore, these three biomarkers are effectively redundant.
We have reported the use of non-targeted Flow Infusion 
nominal mass LC–MS fingerprinting of urine samples to 
identify potential dietary exposure biomarker signals whose 
structure was confirmed later using targeted high resolution 
MS/MS fragmentation (Lloyd et al. 2011b). In the current 
work, for the first time, we report the use of Flow Infusion-
High Resolution Fingerprinting (FIE-HRMS) combined 
Table 1  Validation in a free-living population of previously identified food intake biomarkers
All markers appeared discriminatory in post-prandial urine collections with the following implemented thresholds: RF Importance scores 
> 0.001, P-values < 0.05, AUC > 0.8 (see Supplemental data 3 for further details)
MSI metabolomics standards initiative
Food or beverage consumed Biomarker Ionization products MSI level and reference
Rye bread 2-Hydroxy-N-(2-hydroxyphenyl)
acetamide (HHPAA) glucuronide
[M−H]1− 2 (Beckmann et al. 2013; Zhu et al. 
2016)
Rye bread Isopropyl 2-hydroxyphenylcarba-
mate (benzoxazinoid metabolite)
[M−H]1− 2 (Zhu et al. 2016)
Wholegrain/rye bread and coffee Ferulic acid 4-o-sulfate [M−H]1−, [M−SULP−H]1− 1 (Bondia-Pons et al. 2013; 
Edmands et al. 2011)
Wholegrain/rye bread and coffee Ferulic acid 4-o-glucuronide [M−H]1− 1 (Edmands et al. 2011)
Coffee Caffeine [M+H]1+ 1 (Rothwell et al. 2014)
Coffee Trigonelline (N-methyl nicotinate) [M+Na]1+ and [M+Na]1+ 13C 1 (Rothwell et al. 2014)
Sweetened-breakfast cereal Sucrose [M−H]1−, [M+Na]1+, [M+K]1+ 1 (Beckmann et al. 2016)
Salmon Anserine [M−H]1−, [M+H]1+, [M+H]1+ 
13C, [M+Na]1+ [M+K]1+
1 (Lloyd et al. 2011b)
Salmon Trimethylamine N-oxide [2M+H]1+ 1 (Lloyd et al. 2011b)
Broccoli S-Methyl-l-cysteine sulfoxide [M+Na]1+ 1 (Edmands et al. 2011)
Wine/grapes Tartaric acid [M−H]1−, [M−H]1− 13C, 
[M+Na−2H]1−
1 (Garcia-Perez et al. 2016)
Almonds 4-Hydroxy-5-(3,4-
dihydroxyphenyl)-valeric acid
[M−H]1−, [M+Na]1+ 2 (Edmands et al. 2011; Sánchez-
Patán et al. 2012)
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with Random Forest feature selection for direct discov-
ery and identification structurally, at high mass accuracy 
(1–5 ppm), of dietary exposure biomarkers in urine samples. 
Despite not being specifically targeted for measurement in 
the present study, these previously published biomarkers 
proved to discriminate between fasting and post-prandial 
urine samples from a free-living population, and so help 
validate our intervention study design for dietary exposure 
biomarker technology development in a ‘real world’ situa-
tion. The considerable inter- and intra-individual variability 
in human metabolite profiles in urine poses considerable 
challenges for data normalization in metabolomics stud-
ies seeking information on dietary exposure (Assfalg et al. 
2008). We have addressed this problem by developing and 
validating standardized methods for both the management of 
participants and for urine sampling in food-based interven-
tions in free-living individuals (Brownlee et al. 2010) and 
also for acute postprandial studies in a controlled environ-
ment (Fave et al. 2011; Lloyd et al. 2011b). Key features of 
these study protocols include behavioral restrictions, e.g. no 
alcohol and the consumption of a standardized meal in the 
evening before a clinic visit to provide an informative fast-
ing urine sample immediately before the start of a dietary 
intervention. We hypothesized that a standardized evening 
meal would help provide a ‘normalized’ metabolic back-
ground against which differences in urine chemistry from 
either previous habitual dietary intake prior to clinic visit or 
in response to acute food intake during the test day could be 
detected (Fave et al. 2011; Lloyd et al. 2011b; Scalbert et al. 
2009; Walsh et al. 2006). We tested that hypothesis in the 
current study in which participants followed a 3-day meal 
plan twice; on one occasion a standardized evening meal was 
consumed on the Pre-day whilst on the other occasion a low 
polyphenol meal of the participant’s choice was consumed. 
We observed that the majority of markers appeared discrimi-
natory after both the standardized ‘normalizing’ meal and 
the low polyphenol meal of the participant’s choice, suggest-
ing that the use of a strictly controlled standard evening meal 
immediately before a food intervention trial is not essential 
for biomarker discovery. However, we do not know whether 
removing all restrictions on the choice of evening meal on 
the Pre-day would provide satisfactory fasting/FMV samples 
for subsequent biomarker discovery. The standard evening 
meal was designed to be low in polyphenols: it is possible 
that this had a similar effect to that of the self-chosen low 
polyphenol meal against which it was tested. This remains 
to be investigated.
3.2  Biomarker generalizability assessment using 
different food formulations
During the intervention period, several foods were intro-
duced multiple times using different preparation, processing 
and cooking methods and were provided in different portion 
sizes as appropriate (Food Standards Agency 1994). This 
provided an opportunity to determine whether previously 
identified biomarkers for specific foods were generalizable 
when each food was consumed after use of different process-
ing or preparation methods. Here we consider four examples 
of food and biomarker combinations viz. tartaric acid for 
grape exposure (Garcia-Perez et al. 2016); rhamnitol for 
apple exposure (Posma et al. 2017); DHPPA glucuronide for 
wholegrain exposure (Bondia-Pons et al. 2013); and anser-
ine for meat exposure (Dragsted 2010; Lloyd et al. 2011b). 
To illustrate the approach, Table 2 shows data for intake 
of grapes and grape products through the six experimental 
days and the utility of tartaric acid as a biomarker of grape 
exposure. Supplemental data 4 shows the complete data for 
all four exemplar foods and their corresponding biomarkers. 
Grapes were consumed at different meal times during the 
day as both white and red grape products, including: grape 
juice (pasteurized/heat-treated/concentrated), raisins (dried), 
wine (fermented), whole grapes, sparkling grape juice (car-
bonated drink). The composition of urine samples collected 
2–3 h after each meal (post breakfast, post-lunch, and post-
dinner) was compared with that of a fasting sample from 
earlier the same day and differences tested using Random 
Forest classification modelling (Table 2). In addition, we 
quantified the concentration of tartaric acid in FMV urine on 
the following day. Tartaric acid was discriminatory after the 
consumption of all grape product formulations (Table 2 and 
Supplemental data 4). After a large or medium portion expo-
sure (i.e. grape juice/wine etc.) tartaric acid was discrimi-
natory in the immediate and the next-but-one post-prandial 
urine sample (2–3 h after exposure), but when a smaller dose 
was consumed (e.g. a berry smoothie containing 10% grape 
juice) the biomarker did not appear discriminatory until the 
next-but-one urine collection (> 6 h post-prandial; Supple-
mental data 4). For the day when no grape products were 
consumed, the tartaric acid concentration in FMV urine on 
the following day was < 1 µg/mL compared with concentra-
tions between 9.28 and 26.24 µg/mL after consumption of 
a range of types and portions sizes of grape-derived foods 
and beverages (Table 2).
Tartaric acid occurs in grapes at relatively high concen-
trations (Ribéreau-Gayon et al. 2006; Velioglu 2009) and 
has been identified as a biomarker of wine or grape/grape 
juice consumption (Garcia-Perez et al. 2016; Regueiro et al. 
2014). Our data suggest that it may be a generic biomarker 
of intake of all grape-derived foods and beverages. Urinary 
excretion of tartaric acid peaks between 4 and 8 h post con-
sumption, the majority of the excretion occurs in the first 
12 h and urinary concentrations decline close to baseline 
after 24 h (Garcia-Perez et al. 2016). This continued excre-
tion of tartaric acid for 12 + h after grape product consump-
tion explains why tartaric acid concentration remained 
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relatively high (10.44 µg/mL) in the FMV following multiple 
intakes of grape juice on experimental day 5 and this marker 
was less discriminatory in the post-breakfast urine on the 
last study day. Additionally the formulation of grape product 
may also have influenced the concentration of tartaric acid 
measured in the FMV after the menu day. It has previously 
been shown that raisins have a higher concentration of tar-
taric acid than wine and grapes (Spiller and Spiller 2001) 
and grape juice has a lower concentration than wine and 
grapes due to the detartration process (Kodama et al. 2001; 
Soyer et al. 2003), which is reflected in our results (Table 2).
In this study, apple was consumed on two experimen-
tal days as a whole fruit, as a component of a mixed berry 
smoothie, juice (from concentrate), and within a cooked, 
sweetened pie. Rhamnitol appeared discriminatory after 
exposure to a medium portion size of all apple-containing 
food formulations and at a high concentration in the FMV 
the following day and was absent from urine collected after 
the consumption of meals not containing apple (Supplemen-
tal data 4) in agreement with previously published literature 
(Posma et al. 2017). However, the marker did not appear 
discriminatory after consuming a single smaller portion of 
apple in a pie (27 g apple) which suggests that this putative 
biomarker may not be sufficiently sensitive for detecting 
consumption of low intakes of this fruit.
Participants consumed wholegrain as rye bread (with 
and without a sourdough starter, toasted and untoasted), 
wholegrain bread (with and without kibbled malted wheat, 
toasted and untoasted), porridge oats (microwaved with milk) 
and wholegrain pasta (extruded). DHPPA glucuronide was a 
discriminatory biomarker for wholegrain foods, in general, 
but had stronger discriminatory power for toasted wholegrain 
bread and wholegrain pasta (Supplemental data 4) and was 
less explanatory for porridge oats consumption. Based on RF 
feature selection, several previously reported urine metabo-
lites were highly ranked as putative biomarker candidates for 
wholegrain consumption, but many also correlated with recent 
exposure to other non-wholegrain foods (data not shown), 
and were deemed not to be wholegrain-specific. In agreement 
with published literature (Bondia-Pons et al. 2013), DHPPA 
glucuronide emerged as a discriminatory biomarker specifi-
cally for wholegrain exposure in this study. However, DHPPA 
glucuronide appeared to be a stronger discriminatory marker 
for exposure for some heat/thermally treated processed who-
legrain foods such as wholegrain pasta, a thermally extruded 
Table 2  Provision of grapes and grape products in each meal/snack throughout 6 experimental days and the utility of tartaric acid as a biomarker 
of grape consumption in different food/beverage formulations
Menu plans illustrate the grape content of successive meals on each of 6 experimental days. For a signal/biomarker to appear discriminatory, the 
following thresholds were implemented: Random Forest (RF) Importance scores > 0.002, P-values < 0.05, area under the receiver operator char-
acteristic (ROC) curve (AUC) 0.9 (highlighted in bold). Lower thresholds indicated putative discriminatory biomarkers (RF Importance scores 
> 0.001 < 0.002, AUC > 0.8 < 0.9) and deemed worthy of investigating further (highlighted in italics)
Experi-
mental 
day
Meal Food component Grape 
consump-
tion (g)
Portion size AUC Mean tartarate concentration in 
FMV µg/mL (± std error) of fol-
lowing day
1 Breakfast No grape product 0 N/A 0.72 11.03 ± 1.79
1 Lunch No grape product 0 N/A 0.56
1 Dinner Red wine 200 Large 0.93
2 Breakfast Red berry smoothie (10% grape) 31 Small 0.79 26.24 ± 4.38
2 Lunch No grape product 0 N/A 0.94
2 Dinner Raisins 43 Medium 0.87
3 Breakfast No grape product 0 N/A 0.87 15.8 ± 2.24
3 Lunch No grape product 0 N/A 0.95
3 Dinner White wine 201 Large 0.88
4 Breakfast No grape product 0 N/A 0.67 0.70 ± 0.14
4 Lunch No grape product 0 N/A 0.62
4 Dinner No grape product 0 N/A 0.74
5 Breakfast Red grape juice 204 Medium 0.91 10.44 ± 1.31
5 Lunch Red grapes 125 Medium 0.98
5 Afternoon snack & dinner Red grapes & Red grape juice 208 Large 1
6 Breakfast White grape juice 204 Medium 0.82 9.28 ± 1.11
6 Lunch White grapes 125 Medium 0.94
6 Afternoon snack & dinner White grapes & white grape juice 228 Large 0.93
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wholegrain product and toasted bread when compared with 
untoasted bread, bread rolls and porridge oats.
Glucuronidated DHPPA was a poor marker on experi-
mental day 6 after a lead-in day (experimental day 5) where 
there had been no consumption of wholegrain products and 
two medium portions of wholegrain on experimental day 6. It 
would have been expected that glucuronidated DHPPA con-
centration in the FMV of day 6 to be the lowest for the whole 
experimental period (instead it was higher than for experimen-
tal day 3-supplemental data 4). On that basis it should have 
provided a better test of the utility of the putative biomarker 
after consumption of the wholemeal rolls on experimental day 
6. DHPPA is a metabolite of alkylresorcinols originating from 
the wholegrain bran fraction (Landberg et al. 2008). A poten-
tial limitation of our analysis is that for all of the wholegrain 
foods used in this intervention, information on the wholemeal 
wheat/rye flour content and ultimately the bran content was 
obtained from the food packaging, so there could potentially 
be an error associated with this.
Anserine proved to be a marker of consumption of salmon, 
cod and chicken (Supplemental data 4), but not of canned tuna, 
shellfish (prawns) or of red meat (beef, pork). There was a 
dose-dependent relationship  (R2 = 0.62, Supplemental data 
5) between consumption of poultry and fish (not including 
shellfish) and anserine concentration in FMV urine on the day 
following consumption of the test food. Anserine is found at 
relatively high concentrations in the muscle of many oily fish 
species (Abe 1983; Abe et al. 1993) and we have reported 
greatly elevated concentrations of anserine in urine after con-
sumption of smoked salmon (Lloyd et al. 2011b). However, 
anserine was not discriminatory after consumption of canned 
tuna and prawns, despite much research suggesting that high 
levels can be found in these meats (Jones et al. 2011). The 
fact that anserine did not appear discriminatory after red meat 
(beef, pork) consumption was expected because these foods 
contain relatively low concentrations of anserine (Aristoy and 
Toldrá 2004; Dragsted 2010).
Overall, despite only investigating a limited number of 
different formulations of foods it was clear that some bio-
markers can be markers of food consumption only when 
prepared in a certain way, while others can be food-specific 
biomarkers, independent of the processing/cooking method. 
Multiple markers or a panel of markers for food groups/
unique foods would need to be developed to overcome these 
issues, while continuing to discover and develop unique food 
group biomarkers.
3.3  Relationships between quantities 
of foods/beverages consumed and urinary 
concentrations of putative biomarkers
In the MAIN Study participants consumed different por-
tion sizes of several  foods(18,19) that were categorized as 
small, medium, large and very large, based on UK FSA 
portion sizes (Food Standards Agency 1994). Although 
the kinetics of individual biomarker excretion differ and 
may be influenced by the food from which each metabo-
lite is derived (Dragsted et al. 2018), for this comparison 
we opted to measure concentrations in FMV urine samples 
only since this spot urine type may be particularly useful 
for simultaneous assay of a comprehensive range of food 
intake biomarkers. In general, urinary concentrations of 
putative biomarkers increased with greater portion sizes of 
the test food/beverage (Fig. 1). As grape-product portion 
sizes increased from ‘small’ the absolute concentration of 
tartaric acid increased significantly too (Fig. 1a and Supple-
mental data 4 and 5a). Tartaric acid can undergo bacterial 
digestion, and it has been proposed previously that there are 
inter-individual differences in tartaric acid excretion due to 
differences in gut microbiota between individuals (Garcia-
Perez et al. 2016). Apple products were consumed on only 
two experimental days and on one of these days a different 
formulation was consumed at each main meal to achieve a 
‘large’ level of exposure; rhamnitol levels in the next day 
FMV were recorded as 1.85 µg/mL (Supplemental data 4). A 
FMV sample following a day when no apple products were 
consumed provided a ‘small’ exposure level (i.e. < 1 portion 
per day) and rhamnitol levels were found to be 0.52 µg/mL. 
Rhamnitol levels also exceeded 1.00 µg/mL in FMV samples 
following days with no expected exposure to apple products, 
however a more detailed investigation of processed foods 
consumed on these days often indicated apple products as an 
ingredient (data not shown). These factors probably explain 
why only a weak trend in the increase in concentration 
of rhamnitol was observed as the portion sizes increased, 
resulting in an insignificant t test statistic and a Spearmans 
co-efficient of only 0.18 (Fig. 1b and Supplemental data 5a).
The aglycone of DHPPA and the biotransformation prod-
uct, DHPPA sulfate, were both available commercially as 
chemical standards and used to examine wholegrain expo-
sure. Both of these markers demonstrated a good correla-
tion (Supplemental data 5a; 0.49 and 0.59 respectively) with 
wholegrain exposure (Fig. 1c, b). The absolute concentra-
tions of anserine in FMV urines correlated well (Supple-
mental data 5a; 0.62) against the portion size of poultry and 
oily fish consumed the day before (Fig. 1e). Carnitine is 
present at high concentrations in red meat (Dragsted 2010) 
and its concentration in FMV urine showed a good correla-
tion with red-meat portion size consumed the previous day 
(Fig. 1f). TMAO (Trimethylamine-N-oxide) is a published 
fish marker (Dragsted 2010; Lloyd et al. 2011b) and showed 
a significant increase in concentration as the portion size 
increased (Fig. 1g and Supplemental data 5a). It has been 
shown recently that chronic red meat exposure can cause a 
small increase in urinary TMAO due to gut microbial pro-
duction from carnitine (Wang et al. 2018) however sufficient 
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detail was not provided to determine if fish products were 
included in the menu design; urinary TMAO levels were 
much lower than those reported after fish exposure in the 
present study.
To broaden the range of investigated food groups 
we quantified other published markers representing 
brassica (SFN-NAC: D,L-Sulforaphane-N-acetyl-l-cysteine 
(Andersen et  al. 2013)) and cocoa (3-methylxanthine 
(Llorach et al. 2013)). Both markers also showed an increase 
in absolute concentration in urine samples as the portion 
size increased (Fig. 1h–i). To take into account relative 
differences in fluid intake between participants all FMV 
Fig. 1  Boxplots of absolute concentrations of selected biomarkers in 
refractive index adjusted FMV urine the day after consumption of 
the test foods against portion size of foods/beverages consumed. a 
Tartaric acid for grape; b Rhamnitol for apple; c DHPPA-3-Sulfate 
for wholegrain; d DHPPA for wholegrain; e Anserine for poultry/
fish; f Carnitine for red meat; g TMAO for fish h SFN-NAC: d,l-
Sulforaphane-N-acetyl-l-cysteine for brassica; i 3-methylxanthine 
for cocoa. Significance values (t test) and Spearmans co-efficients are 
shown in supplemental data 5a
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urine samples were normalized by refractive index prior to 
analysis to ensure all MS measurements were made within 
a similar dynamic range. These data however do not take 
into account differences in the total volume of individual 
FMV urines which may account for some of the variabil-
ity observed in Fig. 1. However after adjustment for FMV 
excreted volume (Supplemental data 5b), the same conclu-
sions are made with regards to the Spearman correlation and 
P-values for all biomarkers.
4  Strengths and limitations of study
The data presented focus on determining the utility of the 
food intervention study design and the urine sampling strat-
egy for confirming or refuting the usefulness of putative 
biomarkers for a range of related foods and beverages. A 
major strength of the study design was the desire to expose 
participants simultaneously (and for some foods multiple 
times) to a comprehensive range of foods representing the 
main components of their habitual diet, rather than providing 
foods as isolated single interventions. This approach offered 
opportunity to confirm the ability of putative biomarkers to 
report exposure to specific foods/food groups in the same 
study population against a variable background of exposure 
to other foods. Likewise, many target foods were presented 
in multiple formulations, including the use of different pro-
cessing methods. Combined with the fact that participants 
prepared and consumed all meals and collected samples 
in their own home, these food intervention design attrib-
utes allowed us to examine biomarker performance under 
conditions of much more realistic simulated habitual eat-
ing behavior. From a practical perspective it is worth not-
ing that in some cases the best candidate markers are likely 
to be sulfate or glucuronides but surrogate biomarkers may 
need to be selected for future quantification and use in moni-
toring nutrition due to lack of commercial sources or cost 
considerations.
5  Concluding remarks
We designed and tested a dietary intake biomarker discovery 
and validation strategy based on a comprehensive food inter-
vention study involving free-living individuals who prepared 
and consumed the test meals and collect urine samples at 
home. The demonstration of the utility of spot urine sam-
ples, in combination with robust dietary biomarkers to report 
multiple diet components (despite major sources of vari-
ance) will allow the future validation of dietary biomarker 
technology in epidemiological studies. We feel that multi-
ple, well-spaced spot samples collected over several weeks 
would be able to capture habitual exposure to a wide range 
of food groups. The ultimate aim of our studies is to deploy 
a comprehensive biomarker panel able to aid in monitor-
ing habitual dietary exposure in clinical trials or population 
surveys at a range of scales.
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